Related references
Note: Only part of the references are listed.Regulation of Postsynaptic Function by the Dementia-Related ESCRT-III Subunit CHMP2B
Romain Chassefeyre et al.
JOURNAL OF NEUROSCIENCE (2015)
Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis
Julia K. Goetzl et al.
ACTA NEUROPATHOLOGICA (2014)
TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions
Michael D. Gallagher et al.
ACTA NEUROPATHOLOGICA (2014)
TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia
Marka van Blitterswijk et al.
ACTA NEUROPATHOLOGICA (2014)
Pathogenesis/genetics of frontotemporal dementia and how it relates to ALS
Janis-Bennion Callister et al.
EXPERIMENTAL NEUROLOGY (2014)
Lysosome size, motility and stress response regulated by fronto-temporal dementia modifier TMEM106B
Massimiliano Stagi et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2014)
Alterations in microRNA-124 and AMPA receptors contribute to social behavioral deficits in frontotemp oral dementia
Eduardo Gascon et al.
NATURE MEDICINE (2014)
The frontotemporal lobar degeneration risk factor, TMEM106B, regulates lysosomal morphology and function
Owen A. Brady et al.
HUMAN MOLECULAR GENETICS (2013)
Syntaxin 13, a Genetic Modifier of Mutant CHMP2B in Frontotemporal Dementia, Is Required for Autophagosome Maturation
Yubing Lu et al.
MOLECULAR CELL (2013)
Molecular Mechanisms of the Membrane Sculpting ESCRT Pathway
William Mike Henne et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Strikingly Different Clinicopathological Phenotypes Determined by Progranulin-Mutation Dosage
Katherine R. Smith et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
Progressive neuronal inclusion formation and axonal degeneration in CHMP2B mutant transgenic mice
Shabnam Ghazi-Noori et al.
BRAIN (2012)
Membrane Orientation and Subcellular Localization of Transmembrane Protein 106B (TMEM106B), a Major Risk Factor for Frontotemporal Lobar Degeneration
Christina M. Lang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Reversal of pathology in CHMP2B-mediated frontotemporal dementia patient cells using RNA interference
Troels Tolstrup Nielsen et al.
JOURNAL OF GENE MEDICINE (2012)
TMEM106B, the Risk Gene for Frontotemporal Dementia, Is Regulated by the microRNA-132/212 Cluster and Affects Progranulin Pathways
Alice S. Chen-Plotkin et al.
JOURNAL OF NEUROSCIENCE (2012)
TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort
Julie van der Zee et al.
BRAIN (2011)
Frontotemporal Dementia Caused by CHMP2B Mutations
A. M. Isaacs et al.
Current Alzheimer Research (2011)
Phenotypic signatures of genetic frontotemporal dementia
Jonathan D. Rohrer et al.
CURRENT OPINION IN NEUROLOGY (2011)
Charged Multivesicular Body Protein 2B (CHMP2B) of the Endosomal Sorting Complex Required for Transport-III (ESCRT-III) Polymerizes into Helical Structures Deforming the Plasma Membrane
Gilles Bodon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers
N. Finch et al.
NEUROLOGY (2011)
Accelerated Lipofuscinosis and Ubiquitination in Granulin Knockout Mice Suggest a Role for Progranulin in Successful Aging
Zeshan Ahmed et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
The role of ESCRT proteins in fusion events involving lysosomes, endosomes and autophagosomes
Daniel Metcalf et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2010)
Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations
Hazel Urwin et al.
HUMAN MOLECULAR GENETICS (2010)
CHMP2B mutants linked to frontotemporal dementia impair maturation of dendritic spines
Agnes Belly et al.
JOURNAL OF CELL SCIENCE (2010)
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP43 inclusions
Vivianna M. Van Deerlin et al.
NATURE GENETICS (2010)
Lysosomal Storage Disease: Revealing Lysosomal Function and Physiology
Emma J. Parkinson-Lawrence et al.
PHYSIOLOGY (2010)
Silencing by small RNAs is linked to endosomal trafficking
Young Sik Lee et al.
NATURE CELL BIOLOGY (2009)
Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity
Derrick J. Gibbings et al.
NATURE CELL BIOLOGY (2009)
Frontotemporal dementia linked to chromosome 3 (FTD-3) - current concepts and the detection of a previously unknown branch of the Danish FTD-3 family
S. G. Lindquist et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
A novel deletion in progranulin gene is associated with FTDP-17 and CBS
Luisa Benussi et al.
NEUROBIOLOGY OF AGING (2008)
CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro
Julie van der Zee et al.
HUMAN MOLECULAR GENETICS (2008)
Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease
Maria Filimonenko et al.
JOURNAL OF CELL BIOLOGY (2007)
A reassessment of the neuropathology of frontotemporal dementia linked to chromosome 3
Ida Elisabeth Holm et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2007)
ESCRT-III dysfunction causes autophagosome accumulation and neurodegeneration
Jin-A Lee et al.
CURRENT BIOLOGY (2007)
Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia
G Skibinski et al.
NATURE GENETICS (2005)
The prevalence and causes of dementia in people under the age of 65 years
RJ Harvey et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
The prevalence of frontotemporal dementia
E Ratnavalli et al.
NEUROLOGY (2002)
Clinical and pathological diagnosis of Frontotemporal Dementia - Report of the work group on Frontotemporal Dementia and Pick's disease
GM McKhann et al.
ARCHIVES OF NEUROLOGY (2001)
Share Paper
